JANX

JANX

USD

Janux Therapeutics Inc. Common Stock

$27.010+0.240 (0.897%)

Reaalajas hind

Healthcare
Biotehnoloogia
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$26.770

Kõrge

$27.660

Madal

$26.330

Maht

1.16M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

1.6B

Tööstusharu

Biotehnoloogia

Riik

United States

Kauplemisstatistika

Keskmine maht

0.91M

Börs

NGM

Valuuta

USD

52 nädala vahemik

Madal $21.73Praegune $27.010Kõrge $71.71

Seotud uudised

Analyst Upgrades

Barclays Initiates Coverage On Janux Therapeutics with Overweight Rating, Announces Price Target of $47

Barclays analyst Etzer Darout initiates coverage on Janux Therapeutics with a Overweight rating and announces Price Target of $47.

Vaata rohkem
Barclays Initiates Coverage On Janux Therapeutics with Overweight Rating, Announces Price Target of $47
Analyst Upgrades

Truist Securities Initiates Coverage On Janux Therapeutics with Buy Rating, Announces Price Target of $100

Truist Securities analyst Asthika Goonewardene initiates coverage on Janux Therapeutics with a Buy rating and announces Price Target of $100.

Vaata rohkem
Truist Securities Initiates Coverage On Janux Therapeutics with Buy Rating, Announces Price Target of $100
Analyst Upgrades

Stifel Reinstates Buy on Janux Therapeutics, Announces $45 Price Target

Stifel analyst Bradley Canino reinstates Janux Therapeutics with a Buy and announces $45 price target.

Vaata rohkem
Stifel Reinstates Buy on Janux Therapeutics, Announces $45 Price Target